Printer Friendly

Israeli Biotech Firm Produces New Drug for Gaucher's Disease.

<![CDATA[ An Israeli firm has passed the first hurdle in gaining FDA approval for a new treatment for Gaucher's disease.]]>

To see the full article, click here:

COPYRIGHT 2009 Israel National News
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2009 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Protalix Biotherapeutics Inc.'s taliglucerase alfa
Publication:Arutz Sheva/Israel National News (Beit El, Israel)
Geographic Code:7ISRA
Date:Dec 10, 2009
Previous Article:Court: Visiting Jailed Terrorists not an Overriding Need.
Next Article:Israeli Envoy to US X-s Out J Street.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters